NAUTILUS BIOTECHNOLOGY INC.
-
USD
(-)
- 15 min delayed data - NASDAQ Stocks
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | NAUT |
| ISIN: |
NAUTILUS BIOTECHNOLOGY INC. news, videos and press releases - Page 2
For more news please use our advanced search feature.
NAUTILUS BIOTECHNOLOGY INC. - More news...
NAUTILUS BIOTECHNOLOGY INC. - More news...
- 02/23/2023 - 11:05 Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
- 02/21/2023 - 13:00 Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference
- 01/26/2023 - 13:00 Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
- 01/26/2023 - 12:45 Nautilus Biotechnology Expands to San Diego
- 01/19/2023 - 13:00 Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
- 11/16/2022 - 13:00 Nautilus Biotechnology Launches “First Access Challenge”
- 11/01/2022 - 10:05 Nautilus Biotechnology Reports Third Quarter 2022 Financial Results
- 10/05/2022 - 12:00 Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022
- 09/23/2022 - 12:00 Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit
- 08/30/2022 - 12:00 Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
- 08/02/2022 - 10:48 Nautilus Biotechnology Reports Second Quarter 2022 Financial Results
- 08/01/2022 - 20:05 Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development
- 07/13/2022 - 12:00 Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
- 05/03/2022 - 10:00 Nautilus Biotechnology Reports First Quarter 2022 Financial Results
- 04/12/2022 - 12:00 Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development
- 04/07/2022 - 12:00 Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
- 04/04/2022 - 12:00 Nautilus Biotechnology to Present at EuPA and AACR Meetings
- 03/31/2022 - 20:05 Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors
- 02/24/2022 - 11:00 Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results
- 02/16/2022 - 21:05 Nautilus to Participate in the 42nd Annual Cowen Health Care Conference
- 01/27/2022 - 13:00 Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
- 11/02/2021 - 12:00 Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
- 11/02/2021 - 10:00 Nautilus Biotechnology Reports Third Quarter 2021 Financial Results
- 10/11/2021 - 12:00 Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021
- 09/03/2021 - 13:00 Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
- 08/10/2021 - 10:00 Nautilus Biotechnology Reports Second Quarter 2021 Financial Results
